Search by Drug Name or NDC
NDC 70515-0712-01 Alvesco 160 ug/1 Details
Alvesco 160 ug/1
Alvesco is a RESPIRATORY (INHALATION) AEROSOL, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Covis Pharma US, Inc. The primary component is CICLESONIDE.
MedlinePlus Drug Summary
Ciclesonide oral inhalation is used to prevent difficulty breathing, chest tightness, wheezing, and coughing caused by asthma in adults and children 12 years of age and older. Ciclesonide is in a class of medications called corticosteroids. It works by decreasing swelling and irritation in the airways to allow for easier breathing.
Related Packages: 70515-0712-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ciclesonide Oral Inhalation
Product Information
| NDC | 70515-0712 |
|---|---|
| Product ID | 70515-712_8cf0f1e5-eba3-405e-8ef5-ee3231ffd3cb |
| Associated GPIs | 44400017003440 |
| GCN Sequence Number | 058672 |
| GCN Sequence Number Description | ciclesonide HFA AER AD 160 MCG INHALATION |
| HIC3 | B6M |
| HIC3 Description | GLUCOCORTICOIDS, ORALLY INHALED |
| GCN | 24152 |
| HICL Sequence Number | 032691 |
| HICL Sequence Number Description | CICLESONIDE |
| Brand/Generic | Brand |
| Proprietary Name | Alvesco |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ciclesonide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | AEROSOL, METERED |
| Route | RESPIRATORY (INHALATION) |
| Active Ingredient Strength | 160 |
| Active Ingredient Units | ug/1 |
| Substance Name | CICLESONIDE |
| Labeler Name | Covis Pharma US, Inc |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021658 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70515-0712-01 (70515071201)
| NDC Package Code | 70515-712-01 |
|---|---|
| Billing NDC | 70515071201 |
| Package | 1 INHALER in 1 CARTON (70515-712-01) / 60 AEROSOL, METERED in 1 INHALER |
| Marketing Start Date | 2018-03-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 43.1637 |
| Pricing Unit | GM |
| Effective Date | 2023-12-20 |
| NDC Description | ALVESCO 160 MCG INHALER |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis